Status | Study |
Enrolling by invitation |
Study Name: Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated Condition: Rift Valley Fever Date: 2009-03-25 Interventions: Biological: Inactivated, Dried (TSI-GSD 200), RVF Vaccine All subjects: 1.0-mL (SQ)doses on day 0, once |
Completed |
Study Name: Safety and Immunogenicity Study of Rift Valley Fever Vaccine Condition: Rift Valley Fever Date: 2007-12-20 Interventions: Biological: RVF Vaccine Part A: Inactivated, Dried (TSI-GSD 200) RVF vaccine will be given as three 1.0- |
Completed |
Study Name: Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine Condition: Rift Valley Fever Date: 2006-12-21 Interventions: Biological: RVF MP-12 Administer 1 ml SQ |
Completed |
Study Name: Rift Valley Fever in Kenya Condition: Rift Valley Fever Date: 2006-02-02 |